First National Corp MA ADV Sells 10,083 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

First National Corp MA ADV lessened its position in iShares Biotechnology ETF (NASDAQ:IBB) by 63.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,818 shares of the financial services provider’s stock after selling 10,083 shares during the quarter. First National Corp MA ADV’s holdings in iShares Biotechnology ETF were worth $847,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Future Financial Wealth Managment LLC purchased a new position in shares of iShares Biotechnology ETF during the first quarter valued at approximately $27,000. Bbjs Financial Advisors LLC bought a new stake in iShares Biotechnology ETF during the 2nd quarter valued at about $31,000. Pacifica Partners Inc. boosted its position in iShares Biotechnology ETF by 118.2% in the 1st quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock valued at $33,000 after buying an additional 130 shares during the period. YHB Investment Advisors Inc. bought a new position in iShares Biotechnology ETF in the 1st quarter worth about $37,000. Finally, Mather Group LLC. purchased a new position in shares of iShares Biotechnology ETF during the first quarter worth approximately $57,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of iShares Biotechnology ETF stock traded down $0.26 on Wednesday, hitting $142.74. 124,916 shares of the company traded hands, compared to its average volume of 1,479,113. iShares Biotechnology ETF has a 52 week low of $111.83 and a 52 week high of $150.57. The stock’s 50 day moving average price is $145.27 and its 200-day moving average price is $139.22.

iShares Biotechnology ETF Announces Dividend

The company also recently announced a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were issued a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.